CS Paper Radar

Vibe synthesis: hierarchical agentic decision-making for intent-driven multistep molecule synthesis

Jie Chen, Guikun Chen, Feng Wan, Ning Xu, Wen Liu, Yixiang Ruan, Yiyi Qiu, Haohua Li, Wei Wang, Yi Wang, Xiaoxue Wang, Peng Wang, Jiazhou Zhu, Jun Xuan, Chengxi Li, Jianhong Xu, Wenguan Wang, Yiming Mo

cs.AI physics.chem-ph ·submitted 2026-11-12 08:41 UTC · v1

Abstract

The ability to construct complex molecules underpins advances in medicine and the molecular sciences. Yet long-horizon multistep synthesis requires decisions to be revised as evidence accumulates across chemically dependent operations, a capability not readily supported by artificial-intelligence tools and automated platforms organized around predefined tasks and hard-coded workflows. Here we propose and demonstrate a vibe synthesis system (VibeSyn), an intent-driven architecture in which hierarchical agents translate chemist-defined molecular objectives and accumulating evidence into adaptive decisions executed through computational tools and laboratory automation. We evaluate VibeSyn in three demonstrations of increasing scope and autonomy, progressing from evidence-grounded experimental decisions to adaptive execution of a ten-step total synthesis of catharanthine and structure-to-compound synthesis of cyclic peptides containing unnatural amino acids (uAAs). Across the long-horizon campaigns, active human input and simple confirmation account for less than 7.5% and 5.2%, respectively, of recorded workflow actions and outcomes. VibeSyn points towards a future in which chemists define synthetic intent and agent-directed laboratories autonomously navigate the evolving experimental trajectory required to deliver the target compound.

Comment
30 pages, 5 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Multi-Agent Closed-Loop Reasoning for Organic Structure Elucidation from Multimodal Spectra

cs.AI physics.chem-ph ·2026-08-12 ·Bingsen Xue, Zhuojun Jiang, Jianhao Zhang, Mingcheng Gu, Yizhe Yuan +8 more
similarity 0.69
Abstract

Following the molecular discovery and synthesis revolutions, scalable automated structure elucidation from routine spectroscopic data remains an outstanding challenge. Despite decades of computational efforts, no existing system achieved reliable reasoning over unseen spectra. Here, we propose MACROS, a multi-agent system automating structure elucidation by emulating expert iterative hypothesis-testing. Trained on 100M simulated and 1.6M experimental spectra-molecule pairs, it natively supports arbitrary combinations of routine spectroscopic techniques. It achieves unprecedented zero-shot generalization to diverse real-world samples, correctly identifying synthetic compounds, natural products and metabolites above 500 Da with 1D NMR. Remarkably, MACROS spontaneously recovers textbook spectroscopic correlations from unassigned data and exhibits emergent chemical intuition such as a ring-first parsing preference, learning fundamental chemical principles rather than memorizing database patterns. MACROS augments chemists via collaboration to deliver sixfold faster, 40% more accurate elucidation. MACROS establishes a scalable foundation for fully automated structure elucidation, and catalyzes accelerated molecular discovery toward autonomous laboratories.

0.34

From Benchmark to Bench: Can Agents Survive Real-World Drug Discovery?

cs.AI ·2026-10-05 ·Pierre Llompart, Levent Guner, Helen Lai, Alessandro Tibo, Yijie Xu
publishedbenchmark similarity 0.68
Abstract

Agentic systems increasingly coordinate molecular-design tools, but it is unclear which layer of the stack limits outcomes on real projects. We developed MAGI, an open modular agent that authors objectives, launches and monitors optimization, interprets structure--activity relationships, and revises its strategy accordingly. MAGI generates molecules either directly through the LLM or by delegating to REINVENT 4, with scoring services interchangeable behind a common contract. We tested it across nine retrospective lead-optimization campaigns from three pharmaceutical companies, replayed under fixed temporal cutoffs. Both routes produced valid structures: LLM proposals stayed closer to local chemistry and reached comparable or higher primary activity in fewer operations, whereas REINVENT explored broader chemical space. Whether a campaign met its objective depended on the predictive models, not on the generation route: attainment followed model accuracy on the chemistry proposed, dropping once that chemistry moved outside the model's applicability domain. Separately, a blinded evaluation asked whether the MAGI's output could pass as expert work: chemists were not able to discriminate agentic proposals from held-out compounds, and judged the SAR reasoning broadly plausible yet incomplete. Together, these results position MAGI as a coordination layer pluggable into existing computational chemistry workflows. The ceiling on real projects, however, remains currently set by scorer applicability rather than by tool orchestration.

0.26

MADDIE: Multi-Agent Drug Discovery Engine

cs.AI ·2026-10-12 ·Ye Liu, Reza Averly, Avery Meyer, Frazier N. Baker, Ruoxi Gao +2 more
code/data similarity 0.68
Abstract

Drug discovery remains a resource-intensive and time-consuming process, involving billions of dollars and a decade of development to advance a drug to market. While many in silico tools have accelerated this process, operating them still demands substantial time, effort, and expertise from medicinal chemists. Autonomous systems built on Large Language Models (LLMs) have emerged as a promising solution, yet current designs limit their performance. Existing single-agent systems scale poorly to long-horizon, multi-step, and realistic tasks, whereas multi-agent systems typically execute predefined workflows that cannot capture the iterative, non-linear nature of a real drug discovery campaign. Here, we present MADDIE, a multi-agent drug discovery engine. It comprises a central agent, Orchestrator, and four specialized worker agents: HitIdentifier, LeadOptimizer, Synthesizer, and Evaluator, each representing a critical step in a drug discovery campaign. Under Orchestrator's orchestration and coordination, these worker agents are composed into flexible workflows, enabling MADDIE to adapt its strategy and navigate the drug discovery pipeline end-to-end. Across 50 protein targets, MADDIE produces molecules satisfying key property requirements and their synthesis routes, outperforming existing agentic systems, generative models, and general-purpose LLMs by a wide margin. Our analysis reveals how these agents collaborate and that MADDIE can employ different strategies across targets to achieve the campaign's goal, while still being efficient in time and tokens. Together, they demonstrate MADDIE as a low-cost, effective, and efficient autonomous engine for accelerating drug discovery. Code and dataset is available via https://github.com/ninglab/MADDIE.

0.49

Molecular LLM Agents: From Architectural Design to Scientific Autonomy

cs.CL cs.AI ·2026-08-24 ·Jiatong Li, Wengyu Zhang, Weida Wang, Yuxuan Ren, Wei Liu +6 more
similarity 0.67
Abstract · 25pages

Molecular science represents an important frontier for LLM-based agents. Unlike general agents that mainly operate over natural language, code, or web environments, molecular LLM agents must perceive, reason about, and act upon chemical objects across symbolic strings, molecular graphs, 3D conformations, spectra, simulations, and wet-lab measurements. Their capabilities depend on chemically faithful molecular perception, an LLM-centered agent framework, domain-specific tool grounding, and computational or experimental feedback, in addition to planning and tool use. This work develops a conceptual framework for molecular LLM agents from two complementary perspectives. First, we introduce an architectural view of molecular-agent design, covering molecular representation and perception, the agent framework, domain-specific toolboxes, and learning and optimization. Second, we propose a scientific autonomy ladder inspired by staged autonomy in engineering systems, categorizing agents into four levels: L1 assistive or fixed workflows, L2 adaptive computational agents, L3 feedback-aware physical experiment agents, and L4 scientific-agenda agents. Together, these two perspectives establish a comprehensive framework for comparing existing molecular LLM agents, identifying missing capabilities and deployment risks, and guiding the design, evaluation, and deployment of future agents in molecular discovery workflows.

0.23

TMCS: Tool-Grounded Multi-Agent Reasoning for Compositional Chemical Problem Solving

cs.AI cs.CV ·2026-09-28 ·Shengqin Wang, Jie Jin, Yu Cheng, Yihang Chen, Weilin Luo +2 more
similarity 0.66
Abstract

Despite the promise of Large Language Models (LLMs) in computational chemistry, rigorous combinatorial chemistry problems remain difficult because they require quantitatively constrained molecular modification, candidate validation, and systematic revision after failed attempts. Existing tool-augmented chemical agents demonstrate useful planning and tool use, but they rarely provide a unified loop for property-driven molecular optimization and workflow-level composition. To bridge this gap, we propose Tool-Grounded Multi-Agent Reasoning for Compositional Chemical Problem Solving (TMCS), a step-by-step multi-agent framework that formalizes chemical problem solving as an interpretable, tool-augmented workflow. At the task level, specialized agents leverage external tools, few-shot trajectory memory, and structured reflection to iteratively refine solutions. At the workflow level, TMCS chains generation, understanding, editing, description, and optimization into a closed-loop pipeline. Evaluations across multiple chemical tasks demonstrate that TMCS consistently enhances chemical reasoning across both open- and closed-source base models, achieving state-of-the-art performance.

0.12

M3OS: A Monte Carlo Graph Search-Orchestrated Multi-Agent LLM System for Evidence-Traced Molecular Optimization

cs.LG q-bio.BM ·2026-09-28 ·Junjie Wang, Yaowei Jin, Ruohui Tang, Guonan Cui, Haojie Wang +5 more
similarity 0.65
Abstract

Small-molecule optimization integrates medicinal-chemistry reasoning and computational evidence through iterative, multi-objective decisions. When large language models (LLMs) reason over optimization histories stored primarily in conversational context, they must recover candidate identities, prior evaluations, and task constraints to guide subsequent decisions. We present M3OS, a multi-agent LLM system that decouples molecular-design reasoning from optimization-state management through Monte Carlo graph search. A persistent graph links evaluated candidates, parent-child transformations and evaluation evidence, while rewards and visit statistics guide LLM-assisted parent selection. Two branches combine tool-driven candidate generation with knowledge- and case-guided medicinal-chemistry editing. An execution harness controls graph updates through structured output extraction, molecular validation and task-bound evaluation. Agents receive role-specific contexts, while the graph preserves optimization trajectories beyond their active contexts. Across three molecular optimization benchmarks, M3OS achieves higher success rates than baselines, supporting the integration of persistent search state, specialized agents and controlled execution for multi-constraint optimization.

0.21

MoLRSI: A Recursive Self-Improving AI agent for Molecular Discovery

cs.AI ·2026-10-29 ·Yikun Zhang, Xiwei Cheng, Mingze Yuan, Yu Zhang, Brian Shim +13 more
community pick similarity 0.65
Abstract · v2: updated the author list

Molecular discovery requires navigating vast combinatorial search spaces while balancing competing biological objectives. AI agents can automate expert-defined molecular design protocols, but automation alone does not address how to optimize workflows for new tasks or improve their development through experience. Here we introduce MoLRSI, an AI agent that combines systematic optimization of workflows and model architectures with persistent cross-task memory to recursively improve its search policy for molecular discovery. Workflow performance, refinement outcomes, and execution feedback guide subsequent searches, allowing the agent to improve both its workflows and its strategy for developing them. We evaluate MoLRSI in two challenging molecular discovery settings that require balancing competing properties. In antibiotic discovery, MoLRSI developed a screening workflow balancing antibacterial activity, cytotoxicity and structural novelty, achieving an experimental hit rate of 15.9%, compared with 8.7% for a previous expert-led workflow using the same training data and screening library. In de novo peptide-MHC binder design, MoLRSI developed workflows that jointly consider target binding and specificity, producing eight experimentally validated hits against MART-1 and SARS-CoV-1 pMHCs with preferential binding over tested off-targets while Claude Science completely failed. These findings demonstrate how experience-guided workflow optimization can address competing discovery objectives while improving the search strategies used in subsequent campaigns.

0.39

Autonomous Chemical Mechanistic Discovery through Agentic Reasoning and Validation

cs.AI ·2026-09-10 ·Dong Li, Sixuan Mi, Zihao Ye, Huan Xiong, Tao XU +8 more
code/data similarity 0.64
Abstract · This paper has been submitted to Nature Communications

Unraveling reaction mechanisms is central to modern chemistry, yet automating these investigations remains challenging because computational workflows still rely heavily on expert intervention. Here we introduce ARCHE, an autonomous agentic system that integrates a general-purpose reasoning model, a domain-specialized computational chemistry model, and a structured tool registry to transform mechanistic inquiry into a scalable, self-validating process. ARCHE interprets scientific questions, generates and prioritizes mechanistic hypotheses, orchestrates computational workflows, and iteratively refines conclusions based on computed evidence within a closed loop. We validate its capabilities across three increasingly demanding scenarios: reconstructing stereocontrolling transition states and validating the corresponding reaction mechanism in a previously reported asymmetric catalytic reaction; proposing and validating a plausible radical pathway through iterative hypothesis refinement for a recently discovered but unpublished $α$-iodoboronate C-I cleavage reaction; and identifying a chemically interpretable descriptor that governs selectivity in nickel-catalysed migratory cross-coupling reactions. By coupling agentic reasoning with rigorous computational validation, ARCHE advances autonomous mechanistic discovery and establishes a foundation for broader machine-assisted chemical research. The code for ARCHE is publicly available at https://github.com/JetAstra/Arche-Harness.

0.20